N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)propanimidic acid

Metabolite details

Identifier

DDSIZVYRTNDIJL-UHFFFAOYSA-N

InChI Key

DDSIZVYRTNDIJL-UHFFFAOYSA-N

IUPAC name

N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)propanamide

Preferred name

N-(4-aminobutyl)-3-(4-hydroxy-3-methoxyphenyl)propanimidic acid

INN name

—

Synonym

—

ChEBI

CHEBI:186625

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Bioaccumulation of therapeutic drugs by human gut bacteria: cross-feeding metabolite analysis (FIA-MS) (E.rectale;S.salivarius assays)
• Multi-Omics Analysis Reveals Disturbance of Nanosecond Pulsed Electric Field in the Serum Metabolic Spectrum and Gut Microbiota
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• G4_Eubacterium_rectale_DMSO_30_vs_G3_Eubacterium_rectale_Duloxetine_47
• Control_vs_nsPEF_7_day
• G1_PBS_vs_G2_DSS
• Control_vs_CSD
• Control_0d_vs_Treatment_180d